|
Name |
alterporriol H
|
Molecular Formula | C32H26O13 | |
IUPAC Name* |
1,7-dihydroxy-3-methoxy-6-methyl-2-(4,5,6,7,8-pentahydroxy-2-methoxy-7-methyl-9,10-dioxo-6,8-dihydro-5H-anthracen-1-yl)anthracene-9,10-dione
|
|
SMILES |
COc1cc2c(c(O)c1-c1c(OC)cc(O)c3c1C(=O)C1=C(C3=O)C(O)C(O)C(C)(O)C1O)C(=O)c1cc(O)c(C)cc1C2=O
|
|
InChI |
InChI=1S/C32H26O13/c1-9-5-10-11(6-13(9)33)25(36)17-12(24(10)35)7-15(44-3)20(26(17)37)19-16(45-4)8-14(34)18-21(19)28(39)23-22(27(18)38)29(40)31(42)32(2,43)30(23)41/h5-8,29-31,33-34,37,40-43H,1-4H3/t29-,30+,31+,32-/m0/s1
|
|
InChIKey |
WNKYPOGUIDZODB-BVEPWEIPSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 618.55 | ALogp: | 1.1 |
HBD: | 7 | HBA: | 13 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 228.3 | Aromatic Rings: | 6 |
Heavy Atoms: | 45 | QED Weighted: | 0.173 |
Caco-2 Permeability: | -6.517 | MDCK Permeability: | 0.00000582 |
Pgp-inhibitor: | 0.524 | Pgp-substrate: | 0.021 |
Human Intestinal Absorption (HIA): | 0.996 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.995 |
Blood-Brain-Barrier Penetration (BBB): | 0.001 | Plasma Protein Binding (PPB): | 85.66% |
Volume Distribution (VD): | 0.381 | Fu: | 26.53% |
CYP1A2-inhibitor: | 0.28 | CYP1A2-substrate: | 0.866 |
CYP2C19-inhibitor: | 0.012 | CYP2C19-substrate: | 0.051 |
CYP2C9-inhibitor: | 0.253 | CYP2C9-substrate: | 0.124 |
CYP2D6-inhibitor: | 0 | CYP2D6-substrate: | 0.148 |
CYP3A4-inhibitor: | 0.031 | CYP3A4-substrate: | 0.041 |
Clearance (CL): | 3.119 | Half-life (T1/2): | 0.104 |
hERG Blockers: | 0.007 | Human Hepatotoxicity (H-HT): | 0.026 |
Drug-inuced Liver Injury (DILI): | 0.987 | AMES Toxicity: | 0.294 |
Rat Oral Acute Toxicity: | 0.004 | Maximum Recommended Daily Dose: | 0.814 |
Skin Sensitization: | 0.905 | Carcinogencity: | 0.008 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.871 |
Respiratory Toxicity: | 0.02 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
D01XWG | 0.274 | ||||||
D07VLY | 0.270 | ||||||
D0C9XJ | 0.270 | ||||||
D0T5XN | 0.260 | ||||||
D0AZ8C | 0.253 | ||||||
D06GCK | 0.252 | ||||||
D09LBS | 0.250 | ||||||
D0Z2LG | 0.250 | ||||||
D01XDL | 0.239 | ||||||
D01UBX | 0.235 |